July 2018

Boston Scientific Corporation Acquires Cryterion Medical in Transaction Valued at $310M

North America - United States | North America | United States - California

Boston Scientific Corporation acquired the remaining 65% of Cryterion Medical Inc, a privately held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation (AF), that it did not previously own for $202 million. Our firm represented Boston Scientific in both its initial Series A investment in Cryterion Medical and the ultimate acquisition.

Read Boston Scientific’s press release for more information.

Related Legal Services

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.